Post Leonard E: insider trades.
Post Leonard E reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($219K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- POST LEONARD E
Companies
| Company | Relationship | Transactions |
|---|---|---|
| CG Oncology, Inc. (CGON) | Director | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | CG Oncology, Inc. | M | 1,000 | $0.6 | 1,000 | Form 4 |
| 2026-09-15 | CG Oncology, Inc. | S | 1,000 | $72.98 | 0 | Form 4 |
| 2026-08-14 | CG Oncology, Inc. | S | 1,000 | $74.54 | 0 | Form 4 |
| 2026-08-14 | CG Oncology, Inc. | M | 1,000 | $0.6 | 1,000 | Form 4 |
| 2026-07-15 | CG Oncology, Inc. | S | 1,000 | $71.17 | 0 | Form 4 |
| 2026-07-15 | CG Oncology, Inc. | M | 1,000 | $0.6 | 1,000 | Form 4 |
Questions
What stock did Post Leonard E buy or sell?
Post Leonard E reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($219K), across 1 company.
Is Post Leonard E the same person as other filers with this name?
This page covers SEC CIK 1235862 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/post-leonard-e-1235862.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.